Department of Biotechnology has given special emphasis to promote Nanobiotechnology having applications in various sectors of life sciences. Thus the department has initiated funding R&D in this area since 2007. Various scientists/ stakeholders have felt the need to have specific guidelines for evaluation of products in various sector of biological sciences developed through interventions of Nanotechnology. DBT is mandated to bring out manuals / guidelines specifying procedures that will help in regulatory process pertaining to development / commercialization of Nano products in bio-sectors in India.
Accordingly the department (through Indian Society of Nanomedicine) has formulated the draft “Guidelines for evaluation of nanopharmaceuticals in India” after series of consultations with the stakeholders. The department had organized an inter-ministerial meeting recently and the draft guidelines have been further revised.
The Department of Biotechnology invites comments on “Guidelines for evaluation of nanopharmaceuticals in India” from the institutions/ industry/researchers engaged in research & development in Nanobiotechnology. It is requested that comments/ observations pertaining to the same may be conveyed positively by March 10th, 2019 to email@example.com
© 2019 B I R A C